ArticleTherapeutic advances in gastroenterology2021

Preferences and satisfaction of IBD patients after switching from adalimumab 40 mg weekly to 80 mg every other week given as a single injection: the ADASCAL study.

Carlos Taxonera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.